Citigroup Inc Creative Medical Technology Holdings, Inc. Transaction History

Citigroup Inc

  • $150 Billion
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022
SELL
$0.62 - $3.66 $3,416 - $20,170
-5,511 Reduced 45.32%
6,650 $5,000
Q1 2022

May 12, 2022
BUY
$1.33 - $4.54 $16,174 - $55,210
12,161 New
12,161 $47,000

About CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.

CELZ Quotes by TradingView
  • Ticker CELZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,070,300
  • Market Cap $49.8M
  • Description
  • Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for...
More about CELZ
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email